Forum Statistics

Threads
27,996
Posts
550,327
Members
28,693
Latest Member
Rboy101
What's New?

The Paradox of Testosterone and Prostate Cancer

W

Wilson6

VIP Member
Dec 17, 2019
909
1,547
Very interesting read. I've always thought the worst place to be T wise is low to low normal (200 - 450 ng/dl) relative to the development of PCa and high Gleason score cancers.

 
R

rawdeal

TID Board Of Directors
Nov 29, 2013
4,545
3,809
Interesting indeed. By the end of that they seem to think they may have identified a solution via a monthly high-dose injection of testosterone. To my semi-educated self that suggests Test U a helluva lot more than Prop, but their choice was not identified.

They go on to say they "have already developed new drugs . . . . " What could those be? If not Test U, would it be a new Sust-like blend designed for even more of a time-release effect?

And ... will any of us prostate owners live long enough to see this readily available to doctors and drug stores, or will we be able to approximate diy therapy using what is already available IF we ever get that diagnosis.
 
W

Wilson6

VIP Member
Dec 17, 2019
909
1,547
This aligns with the recent Danish longitudinal study comparing AAS vs non-AAS users and cancer dx over time. The incidence of overall cancer was the same, but there were no prostate cancers reported in the AAS users, whereas there were in the non-AAS group. IMO, keep your T in the upper end or low supraphysiologic range for life. Every guy if they live long enough will have PCa, perhaps microscopic but if you look for it on autopsy, you'll find it. The key is to limit proliferation and push the differentiation and that takes T and to keep a lid on it throughout life, not try to stop it once it begins to proliferate uncontrollably. If one looks at this from a global perspective, why is PCa a disease of aging that parallels the decline in T?
 
W

Wilson6

VIP Member
Dec 17, 2019
909
1,547
More evidence is that estrogen is the cause:.. more T, more E Conversion, keep it in check and admittedly speculation, maybe keep E on the lower end of Normal as we get older
Then one would think that MTF trans would have a greater risk of PCa esp among older subjects than cis-men, but they are at least a 2x decr risk. However, their PSA at time of dx is pretty high (suggesting higher Gleason scores) so it might be that in the absence of T, proliferation is accelerated when PCa is present, but in the absence of PCa the low T environment is not favorable for the development of PCa, but when it develops look out below.
 
Glycomann

Glycomann

VIP Member
Jan 19, 2011
1,416
1,572
The answer to prostate cancer is a strong immune system, a clean lifestyle... and no more than 3 women at a time.
 
myosin

myosin

VIP Member
May 27, 2011
1,282
1,614
Then one would think that MTF trans would have a greater risk of PCa esp among older subjects than cis-men, but they are at least a 2x decr risk. However, their PSA at time of dx is pretty high (suggesting higher Gleason scores) so it might be that in the absence of T, proliferation is accelerated when PCa is present, but in the absence of PCa the low T environment is not favorable for the development of PCa, but when it develops look out below.
That’s really interesting actually, never looked at MTF data in that regard… honestly never crossed my mind , but a good aspect to look into more… As a last ditch effort they actually castrated bill bixby :(



  • Observations from several studies led to the hypothesis that increased circulating estrogens might elevate prostate cancer risk and act through the estrogen receptor; this idea is strongly supported by the finding that estrogens enhance androgen-induced prostate cancer in an animal model.
  • https://www.jci.org/articles/view/170809
 
Last edited:
W

Wilson6

VIP Member
Dec 17, 2019
909
1,547
That’s really interesting actually, never looked at MTF data in that regard… honestly never crossed my mind , but a good aspect to look into more… As a last ditch effort they actually castrated bill bixby :(



  • Observations from several studies led to the hypothesis that increased circulating estrogens might elevate prostate cancer risk and act through the estrogen receptor; this idea is strongly supported by the finding that estrogens enhance androgen-induced prostate cancer in an animal model.
  • https://www.jci.org/articles/view/170809
Will give these a read later today. The other thing that came to mind yesterday were the studies on 5ARIs showing a decreased risk of PCa but the degree of malignancy was increased. Same thing you see in MTF, less PCa but higher Gleason Scores. Why, both decrease intraprostatic androgen levels shifting the balance away from differentiation and toward proliferation, so when PCa is induced there are no brakes on the proliferation and differentiation is suppressed so it blows up. Thus only the guys that actually get to the point where it is induced are in trouble with low androgens. IMO, we have to be careful with suppressing E2 too much bc of all the other benefits, and the key is keeping the E2 to T and DHT ratio in check. Letting E2 rise in a decreasing T and DHT environment (older guys) is just asking for trouble. High T and high E2 is fine, low T and high E2 is not.
 
D

DocOxRedox

Member
Feb 25, 2024
20
12
My doc
More evidence is that estrogen is the cause:.. more T, more E Conversion, keep it in check and admittedly speculation, maybe keep E on the lower end of Normal as we get older
I found a research study that covered this as a side note, but were focusing on other causes. I told my doc about my findings and he confirmed that high levels of E are direct contributors to prostate cancer.
 
Glycomann

Glycomann

VIP Member
Jan 19, 2011
1,416
1,572
I think it is interesting that PC emerges later in life when immune function is dropping as are cell cycle check points. Hormone levels shift and dominant ones might be more estrogenic. But, AAS users, whose hormones are all over the place and typically younger, don't seem to have a massive spike in PC compared to general population. I would guess that the major driver is a drop in immune function such as that of natural killer T-cells and others, along with their cytokines, that surveil the body for early cancer cells.
 
Who is viewing this thread?

There are currently 0 members watching this topic

Top